These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14983950)

  • 1. ERSPC: features and preliminary results of France.
    Villers A; Malavaud B; Rebillard X; Bataille V; Iborra F
    BJU Int; 2003 Dec; 92 Suppl 2():27-9. PubMed ID: 14983950
    [No Abstract]   [Full Text] [Related]  

  • 2. ERSPC: features and preliminary results from the Antwerp study centre.
    Nelen V; Thys G; Neels H; Neetens I; Coebergh JW; Dourcy-Belle-Rose B; Denis L
    BJU Int; 2003 Dec; 92 Suppl 2():17-21. PubMed ID: 14983948
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific features of the Italian section of the ERSPC.
    Ciatto S; Gervasi G; Frullini P; Zendron P; Zappa M
    BJU Int; 2003 Dec; 92 Suppl 2():30-2. PubMed ID: 14983951
    [No Abstract]   [Full Text] [Related]  

  • 4. What can be concluded from the ERSPC and PLCO trial data?
    Studer UE; Collette L
    Urol Oncol; 2010; 28(6):668-9. PubMed ID: 21062648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for prostate-specific antigen screening.
    Catalona WJ
    Urology; 2003 Jan; 61(1):17-9. PubMed ID: 12559258
    [No Abstract]   [Full Text] [Related]  

  • 6. ERSPC and PLCO prostate cancer screening studies: what are the differences?
    Schröder FH; Roobol MJ
    Eur Urol; 2010 Jul; 58(1):46-52. PubMed ID: 20362385
    [No Abstract]   [Full Text] [Related]  

  • 7. Informed consent for prostate-specific antigen-based screening.
    Brawley OW
    Urology; 2003 Jan; 61(1):10-2. PubMed ID: 12559255
    [No Abstract]   [Full Text] [Related]  

  • 8. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).
    Roobol MJ; Kirkels WJ; Schröder FH
    BJU Int; 2003 Dec; 92 Suppl 2():48-54. PubMed ID: 14983955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed consent for prostate-specific antigen screening.
    Wilkinson S; Chodak G
    Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer: informing men about their options.
    Mahon SM
    Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
    [No Abstract]   [Full Text] [Related]  

  • 12. Informed consent for prostate-specific antigen screening.
    Carter HB
    Urology; 2003 Jan; 61(1):13-4. PubMed ID: 12559256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
    Richard F
    Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer. How can patients give informed consent?
    Marshall KG
    Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making an informed choice about PSA screening.
    Ward J; Gattellari M
    Aust Fam Physician; 2001 Jul; 30(7):715-6. PubMed ID: 11558209
    [No Abstract]   [Full Text] [Related]  

  • 16. Informed consent for prostate-specific antigen-based screening--European view.
    Ito K; Schrder FH
    Urology; 2003 Jan; 61(1):20-2. PubMed ID: 12559259
    [No Abstract]   [Full Text] [Related]  

  • 17. Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland.
    Kwiatkowski M; Huber A; Stamm B; Lehmann K; Wernli M; Häfeli A; Recker F
    BJU Int; 2003 Dec; 92 Suppl 2():44-7. PubMed ID: 14983954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed consent for prostate-specific antigen testing.
    Gann PH
    Urology; 2003 Jan; 61(1):5-6. PubMed ID: 12559253
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Urol Oncol; 2008; 26(5):533-41. PubMed ID: 18774469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. France to pilot testing for prostate cancer.
    Spurgeon B
    BMJ; 2006 May; 332(7549):1052. PubMed ID: 16675805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.